House Commerce/Health Subcommittee March 20 hearing to include testimony from PhRMA's Lyons.

Executive Summary

HOUSE COMMERCE/HEALTH SUBCOMMITTEE HEARING MARCH 20 is expected to include testimony from former Marion Merrell Dow Chairman Fred Lyons, who heads the Pharmaceutical Research & Manufacturers of America's FDA reform key issue team. Lyons, who is scheduled to retire from Hoechst Marion Roussel, will continue to head PhRMA's FDA reform effort and will retain that role after his term on the PhRMA board expires in April. Former HHS Secretary Louis Sullivan is also understood to be scheduled to appear. In addition, the committee has said previously it wanted FDA Commissioner Kessler to appear at the next hearing. The committee said it would set the hearing date to accommodate Kessler.